Improvement in Clinical TNM Staging Documentation Within a Prostate Cancer Quality Improvement Collaborative

Filson, Christopher P.; Boer, B.C.J. de; Curry, Jon; Linsell, Susan; Ye, Zaojun; Montie, James E.; Miller, David C.

doi:10.1016/j.urology.2013.11.040

Cited by 23 publications

(14 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similar approaches have been used outside of cardiac surgery with similar success through changes in physician behavior. 22 We recognize some limitations to the present study. First, we cannot rule out any systematic bias in the reporting of HAI rates across STS ACSD participants.…”

Section: Discussionmentioning

confidence: 80%

Sources of Variation in Hospital-Level Infection Rates After Coronary Artery Bypass Grafting: An Analysis of The Society of Thoracic Surgeons Adult Heart Surgery Database

Likosky¹,

Wallace²,

Prager³

et al. 2015

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 80%

Sources of Variation in Hospital-Level Infection Rates After Coronary Artery Bypass Grafting: An Analysis of The Society of Thoracic Surgeons Adult Heart Surgery Database

Likosky¹,

Wallace²,

Prager³

et al. 2015

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

show abstract

“…Guideline adherence for radiographic staging of men with newly diagnosed PCa [133] Implementation of novel clinical pathways to address fluoroquinolone resistance and infectionrelated hospitalizations among men undergoing prostate biopsy [134] Implementation of performance feedback and collaborative-wide educational activities to improve documentation of clinical TNM stage in PCa patients [135] Variation in the use of active surveillance for men with low-risk PCa [ Contemporary patterns of care for men newly diagnosed with PCa [42] Positive surgical margins: rate, contributing factors and rate of additional therapy [43] Active surveillance patterns of care in a contemporary PCa registry [44] RP = radical prostatectomy; ADT = androgen deprivation therapy; EAU = European Association of Urology; CAPRA = Cancer of the Prostate Risk Assessment; PSA = prostate-specific antigen.…”

Section: Caesar: Comparative Effectivenessmentioning

confidence: 99%

Prostate Cancer Registries: Current Status and Future Directions

Gandaglia¹,

Bray

Cooperberg

et al. 2016

European Urology

Self Cite

View full text Add to dashboard Cite

Context: Disease-specific registries that enroll a considerable number of patients play a major role in prostate cancer (PCa) research. Objective: To evaluate available registries, describe their strengths and limitations, and discuss the potential future role of PCa registries in outcomes research. Evidence acquisition: We performed a literature review of the Medline, Embase, and Web of Science databases. The search strategy included the terms prostate cancer, outcomes, statistical approaches, population-based cohorts, registries of outcomes, and epidemiological studies, alone or in combination. We limited our search to studies published between January 2005 and January 2015. Evidence synthesis: Several population-based and prospective disease-specific registries are currently available for prostate cancer. Studies performed using these data sources provide important information on incidence and mortality, disease characteristics at presentation, risk factors, trends in utilization of health care services, disparities in access to treatment, quality of care, long-term oncologic and health-related quality of life outcomes, and costs associated with management of the disease. Although data from these registries have some limitations, statistical methods are available that can address certain biases and increase the internal and external validity of such analyses. In the future, improvements in data quality, collection of tissue samples, and the availability of data feedback to health care providers will increase the relevance of studies built on population-based and disease-specific registries. Conclusions: The strengths and limitations of PCa registries should be carefully considered when planning studies using these databases. Although randomized controlled trials still provide the highest level of evidence, large registries play an important and growing role in advancing PCa research and care. Patient summary: Several population-based and prospective disease-specific registries for prostate cancer are currently available. Analyses of data from these registries yield information that is clinically relevant for the management of patients with prostate cancer.

show abstract

“…Filson et al assessed the rate of documenting clinical TNM stage before and after comparative feedback and educational intervention among the initial MUSIC practices. 46 Documentation of TNM stage improved from 58% to 79% of cases after intervention. Reidinger et al found a relatively high rate of PCa detection among 17 MUSIC practices (52%) but significant variability among practices (43% to 70%).…”

Section: Musicmentioning

confidence: 94%

National Prostate Cancer Registries: Contemporary Trends of Prostate Cancer in the United States

et al. 2014

View full text Add to dashboard Cite

Introduction: Randomized clinical trials are considered the gold standard for evidence-based practices but strict inclusion and exclusion criteria, costs to perform them and the time required to design and complete them may limit generalizability, followup and timeliness. Observational studies based on well designed, large volume patient registries may be more flexible in that scope. Such registries can be modified with time to incorporate new treatments as they emerge. Methods: We describe the design, objectives, funding mechanisms and results to date of the major prostate cancer registries in the United States, highlighting as examples PCOS, CaPSUREÔ, PROST-QA, CEASAR, MUSIC and AQUA. Results: Registries and collaborations have provided valuable knowledge for prostate cancer regarding oncologic and health related quality of life outcomes among treatments, changes in disease prevalence, staging, national practice trends and health service utilization. Conclusions: While there are important limitations to observational data, registries will continue to have an important and growing role in advancing prostate cancer care as a complement to data from clinical trials and traditional cohort studies.

show abstract

Improvement in Clinical TNM Staging Documentation Within a Prostate Cancer Quality Improvement Collaborative

Cited by 23 publications

References 13 publications

Sources of Variation in Hospital-Level Infection Rates After Coronary Artery Bypass Grafting: An Analysis of The Society of Thoracic Surgeons Adult Heart Surgery Database

Sources of Variation in Hospital-Level Infection Rates After Coronary Artery Bypass Grafting: An Analysis of The Society of Thoracic Surgeons Adult Heart Surgery Database

Prostate Cancer Registries: Current Status and Future Directions

National Prostate Cancer Registries: Contemporary Trends of Prostate Cancer in the United States

Contact Info

Product

Resources

About